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PURPOSE. Cells of the corneal epithelium and stroma can be distinguished in vivo by different
intermediate filaments, cytokeratins for corneal epithelial cells (CEC) and vimentin for
keratocytes. Isolated and cultured keratocytes change phenotype, losing expression of
keratocyte markers and gaining markers associated with mesenchymal stromal cells (MSC).
This study investigates this change in phenotype in relation to intermediate filament
expression in cultured corneal stromal cells (CSC) compared to CEC.
METHODS. Expression of epithelial markers (CK3, CK12, CK19, pan cytokeratin, E-cadherin),
keratocyte markers (CD34, vimentin), and MSC markers (CD73, CD90, and CD105) were
compared in CEC and CSC by immunocytochemistry and reverse transcription-quantitative
polymerase chain reaction (RT-qPCR). Expression was evaluated at different stages of CSC
culture and compared to another stromal cell type, extracted from Wharton’s jelly (WJ-MSC).
RESULTS. In vivo keratocytes did not express cytokeratins. However, cultured CSC expressed
epithelial-associated CK3, CK12, and CK19, but not other cytokeratins. Expression of
cytokeratins increased as CSC were passaged and decreased as CSC were induced to become
quiescent. Comparatively, WJ-MSC expressed lower levels of CK3, CK12, and CK19, but also
stained for pan cytokeratin and expressed KRT5.
CONCLUSIONS. Cultured CSC undergo phenotypic change during culture, expressing specific
cytokeratin filaments normally associated with CEC. Cytokeratin expression begins as cells
are cultured on plastic and increases with passage. This discovery may influence the way in
which differences are discerned between cultured CEC and CSC. Investigators need to be
aware that the expression of cytokeratins does not necessarily represent epithelial
contamination, and that CEC and CSC may be more related than previously recognized.
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The cells of the corneal epithelium and keratocytes of thestroma are typically characterized and distinguished by the
presence of certain intermediate filaments (IF) and cell surface
markers. The corneal epithelium is a nonkeratinized stratified
squamous epithelium that exists in a constant state of cell
renewal and regeneration. Cellular division occurs at the basal
level and daughter cells move toward the surface, initially
differentiating into transit-amplifying cells and then becoming
terminally differentiated and shed into the tear film, with a
turnover of approximately 4 to 6 days.1 This self-renewing state
is due to the presence of a population of limbal stem cells (LSC)
located in the limbus, the interface between the cornea and the
sclera.2 Limbal stem cells can be distinguished from terminally
differentiated corneal epithelial cells (CEC) by the difference in
expression of specific cytokeratins, alongside other indicators
such as the expression of ABCG2, DNP63, and location.3,4
Terminally differentiated CEC are characterized by expression
of, among others, cytokeratin (CK) 3,5,6 CK12,7–9 and E-
cadherin.10 Inversely, LSC do not express CK3 or CK12, but
have been reported to express CK19,3 CK14,10–12 vimentin,10
and ABCG2.3
The corneal stroma contains a population of cells known as
keratocytes. Under healthy conditions, keratocytes are quies-
cent and exhibit a dendritic morphology.13,14 Keratocytes are
responsible for producing and maintaining extracellular matrix
(ECM) proteins, such as collagen and proteoglycans, and
expression of collagen-I, keratocan, and other ECM proteins is
often used to identify keratocytes.15–17 Cell surface markers
used to identify the keratocyte phenotype include CD133 and
CD34.18–20 As keratocytes are a mesenchymal cell type, derived
from the neural crest, they have never been reported to express
cytokeratins in vivo, and instead have vimentin as the major
IF.21,22 Keratocytes can be isolated from the stroma for in vitro
expansion. However, once transferred to in vitro culture,
particularly in serum-containing medium, they undergo fibro-
blastic phenotypic change, transitioning to an activated
state,23,24 mirroring an in vivo response of keratocytes to
injury.13 Phenotypic changes that occur during in vitro culture
include the loss of CD34, aldehyde dehydrogenase (ALDH) 3A1
and ALDH1A1,18,25,26 and expression of markers such as
CD9027 and a-smooth muscle actin.28 This phenotypic change
is the reason that cultured keratocytes are often referred to as
corneal stromal cells (CSC).
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In vitro, CSC extracted from the limbal region have been
shown to display characteristics of multipotent mesenchymal
stromal cells (MSC),29,30 which conform to criteria stipulated by
the International Society for Cellular Therapy (ISCT).25,31 The
extracted corneal MSC express specific cell surface markers such
as CD73, CD90, and CD105 and possess the ability to
differentiate down the osteogenic, chondrogenic, and adipo-
genic lineages in vitro.31,32 It has also been suggested that there is
a specific corneal stromal stem cell (CSSC), or keratocyte
progenitor cell, that can be extracted from the limbal region of
the stroma and cultured by clonal expansion. This CSSC
conforms to an MSC phenotype but can be differentiated from
MSC by the expression of keratocyte-specific markers such as
keratocan, PAX6, and ALDH3A1.33 However, it has not been
shown whether this phenotype is present within the in vivo
cornea or is a product of in vitro culture. Although keratocytes in
vivo are not associated with cytokeratins, cultured CSC have
been shown by our collaborators to specifically express CK3 in
combination with CD34.34 However, several other groups have
shown that their cultured CSC do not express general
cytokeratins, though this is often through the use of pan
cytokeratin (panCK) antibodies that may not be specific for CK3
or CK19, as a way of demonstrating a lack of epithelial
contamination.30,35,36
Herein, we compare the expression of cytokeratins and cell
surface markers by CEC and cultured CSC. We compare the
expression of these markers at several stages of CSC culture,
including a quiescent phenotype to represent the keratocyte.
To investigate the specificity of expressed cytokeratins, we also
compare to a different stromal cell type: MSC derived from the
Wharton’s jelly of the umbilical cord (WJ-MSC).
METHODS
Materials
All reagents were purchased from Life Technologies, Paisley,
United Kingdom, unless otherwise stated.
Tissue
Human donor tissue was used with approval by the local ethics
research committee and in accordance with the tenets of the
Declaration of Helsinki, following consent obtained from the
donors and/or their relatives. Corneal tissue was obtained from
Manchester Eye Bank. Umbilical cords were obtained, with
consent, from Obstetrics, Queen’s Medical Centre, Notting-
ham. To complete this study, three corneas from distinct
donors and 22 corneoscleral rims (surplus from penetrating
keratoplasty) were required.
Cell and Tissue Culture
Extraction and Culture of Primary Human Corneal
Epithelial Cells. Human primary CEC were generated from
corneoscleral rims by explant culture. Excess sclera was
removed, the rims were cut into two sections, and a small
incision was made in the anterior stroma of each. The
posterior and mid stroma were peeled away using forceps,
leaving the epithelium and a section of stroma. The
epithelium was divided into 12 explants, and each explant
was placed epithelial side up in 3.5-cm-diameter dishes or
two-well glass chamber slides (Nunc Lab-Tek, Thermo
Scientific, Cramlington, UK), coated with 10 lg/mL bovine
fibronectin. Explants were cultured in CnT-20 medium
(CELLnTEC, Bern, Switzerland), maintained in a humidified
environment at 378C, 5% (vol/vol) CO2. Culture medium was
changed every 2 to 3 days.
Extraction and Culture of Primary Human Corneal
Stromal Cells. Human CSC were isolated from corneoscleral
rims. Excess sclera was removed and epithelium and endothe-
lium were detached by gentle scraping. Stromal tissue was
divided into small pieces and digested in 1 mg/mL collagenase
type IA (Sigma-Aldrich, Poole, UK) in medium 199 (M199;
Sigma-Aldrich), supplemented with 20 ng/mL gentamicin and
0.5 ng/mL amphotericin B (antibiotics) for 7 hours at 378C.
Digests were filtered through a 40-lm cell strainer and
pelleted, and CSC were cultured in M199 supplemented with
20% (vol/vol) fetal bovine serum (FBS; Sigma-Aldrich), 2 mM L-
glutamine (Sigma-Aldrich), and antibiotics (mesenchymal
culture medium). Cultured CSC were maintained at 378C, 5%
(vol/vol) CO2, with medium changes every 2 to 3 days. Cells
were passaged using treatment with TrypLE Express.
Differentiation of CSC to a Quiescent Keratocyte
Phenotype. Corneal stromal cells at passage 4 (P4) were
seeded at 10,500 cells/cm2 in six-well plates or eight-well
chamber slides in mesenchymal culture medium and cultured
for 5 days. Cultures were switched to a serum-free differentia-
tion medium: Dulbecco’s modified Eagle’s medium/F12 supple-
mented with 50 lg/mL ascorbate 2-phosphate (Sigma-Aldrich);
10 lg/mL human insulin, 5.5 lg/mL human transferrin, 6.7 ng/
mL sodium selenite; 10 ng/mL human fibroblast growth factor-2;
0.1 ng/mL transforming growth factor-b3; and antibiotics.
Cultures were differentiated for 21 days.
Extraction and Culture of Wharton’s Jelly Mesenchy-
mal Stromal Cells. Umbilical cords were processed within 24
hours of collection. The cord was washed three times in PBS,
immersed in 70% (vol/vol) ethanol for 30 seconds, and washed
once more. Cords were divided into 6-cm sections and cut
open lengthways. The vessels were removed, and the
surrounding Wharton’s jelly was excised and chopped into 2-
mm3 pieces. Explants were placed in six-well plates and
cultured in mesenchymal culture medium at 378C, 5% (vol/vol)
CO2 in a humidified environment, for 7 days, before MSC
colonies were identified growing from the tissue. Wharton’s
jelly MSC were passaged using TrypLE Express and used for
experimentation at P3.
Culture of Immortalized Human Corneal Epithelial
Cells. SV40-immortalized human corneal epithelial cells
(ihCEC)37 were cultured in supplemented basal epithelial cell
medium EpiLife containing 5 mL human keratinocyte growth
supplement and antibiotics. Cells were maintained at 378C, 5%
(vol/vol) CO2, with medium changed every 2 to 3 days.
Immortalized human CEC were utilized for quantitative cell-
based immunofluorescence studies due to difficulties growing
primary CEC on glass-bottom plates.
Sectioning and Immunofluorescent Staining of
Corneas
Whole human corneas were frozen in optimal cutting
temperature compound (VWR, West Sussex, UK). Specimens
were cut into 8-lm sections using a cryostat-microtome (Leica
Microsystems, Milton Keynes, UK) and placed onto slides
coated in 2% (vol/vol) 3-aminopropyltriethoxysilane (Sigma-
Aldrich). Sections were fixed in ice-cold 100% acetone for 30
seconds. After washing in PBS, blocking of nonspecific protein
binding was performed for 1 hour at room temperature (RT) in
PBS with 1% (vol/vol) bovine serum albumin (BSA; Sigma-
Aldrich), 0.3 M glycine (Sigma-Aldrich), and 3% (vol/vol)
donkey serum (Sigma-Aldrich). Sections were incubated with
primary antibodies (Table) diluted in PBS with BSA and glycine
at 48C overnight. Samples were incubated with secondary
antibodies (donkey Alexa Fluor [AF]-488 or -594) for 1 hour at
RT. Counterstaining with 0.5 lg/mL 40,6-diamidino-2-phenyl-
indole (DAPI) was performed for 10 minutes, and slides were
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mounted in fluorescence mounting medium (Dako, Cam-
bridgeshire, UK). Staining was viewed using an upright
fluorescence microscope (BX51; Olympus, Southend-on-Sea,
UK) and images were captured with a black-and-white camera
(XM-10; Olympus) and Cell^F software (Olympus).
Fluorescence Immunocytochemistry
Samples for immunocytochemistry were cultured in glass
chamber slides and fixed in 4% buffered paraformaldehyde
(PFA; Sigma-Aldrich) for 10 minutes. After washing in PBS, cells
were permeabilized, where necessary, in 0.1% (vol/vol) Triton
X-100 (Sigma-Aldrich) for 5 minutes with subsequent PBS
washing. Immunofluorescent staining was performed to the
same protocol as tissue sections. Counterstaining with AF-488-
conjugated phalloidin was performed for 20 minutes at RT
before counterstaining with DAPI. Chambers were removed
and slides mounted in fluorescence mounting medium before
imaging.
Quantitative Reverse Transcription-Quantitative
Polymerase Chain Reaction (RT-qPCR)
Cells were lysed in RLT buffer and homogenized using
QIAshredder columns (Qiagen, Manchester, UK). Total RNA
was extracted using an RNeasy mini kit (Qiagen) according to
manufacturer’s instructions. RNA was quantified using the L-Vis
plate on a CLARIOstar plate reader (BMG LABTECH, Bucking-
hamshire, UK). RNA (250 ng) was transcribed into cDNA using
Superscript III reverse transcriptase with random hexamer
primers, according to manufacturer’s instructions. For PCR
reactions, 1 lL cDNA was used with inventoried Taqman assays
(Table). Amplification was performed on an Mx3005P PCR
system (Stratagene, Stockport, UK). Reactions were analyzed
using the Real Time PCR Miner algorithm.38 All experimental
values were normalized to endogenous reference gene GAPDH.
Quantitative Cell-Based Fluorescent Immunoassay
Quantitation of fluorescent staining levels was performed
using a plate reader–based assay, similar to an In-Cell Western.
Cells were seeded in 24-well glass-bottom plates (Greiner Bio-
One, Gloucestershire, UK) and cultured until confluence; or,
for quiescent CSC, 21 days to allow for differentiation. Staining
protocol was similar to immunocytochemistry with the
following adjustments: primary antibodies were applied for 1
hour at RT; secondary antibody was AF-680 conjugated; cells
were counterstained with AF-488 phalloidin and DAPI.
Background controls were included, with no primary antibody,
phalloidin, or DAPI. A CLARIOstar plate reader was used to
take bottom-read fluorescent readings at excitation 657 nm,
emission 701 nm (AF-680); excitation 488 nm, emission 535
nm (AF-488); and excitation 360 nm, emission 460 nm (DAPI),
using a well scan of 103 10 at an 11.8-mm diameter. Average
fluorescent intensities were calculated by taking the mean and
correcting for background. Fluorescent intensity was normal-
ized using actin (more stable than DAPI).
Statistical Analysis
Significances were analyzed using GraphPad Prism version 6.02
(La Jolla, CA, USA). Two groups were compared using unpaired
Student’s t-test, and multiple groups were compared using one-
way ANOVA with post hoc Dunnett’s test.
RESULTS
Expression of Epithelial, Keratocyte, and MSC
Markers In Vivo
Whole human corneas were sectioned and stained for a
number of markers (Fig. 1). CK3/12 (Fig. 1i) was detected in
the central epithelium but not in the peripheral/limbal region.
No staining for CK3/12 was seen in the central stroma;
however, low levels of staining could be detected in the
peripheral stroma. CK19 (Fig. 1ii) staining was seen only in the
peripheral epithelium and not in any other part of the cornea.
Staining for the panCK C-11 clone, which detects CK4, 5, 6, 8,
13, and 18, was present in both the peripheral and central
epithelium, but not the stroma of any sample (Fig. 1iii). This
was also true for E-cadherin (Fig. 1iv). Keratocyte markers
vimentin (Fig. 1v) and CD34 (Fig. 1vi) were both expressed in
the stroma, but not the epithelium. For MSC markers, only
CD73 (Fig. 1vii) stained throughout the cornea. CD90 (Fig.
1viii) was not expressed in the peripheral or central epithelium
or peripheral stroma. Figure 1Dviii shows CD90 staining in one
individual cell in the central stroma. CD105 (Fig. 1ix) was
detectable in the cells of the peripheral stroma and some cells
of the central stroma, with possible staining in the epithelium.
Expression of Epithelial Markers in Cultured CEC
and CSC
Cultured CEC and CSC (P4) were immunostained for markers
associated with epithelial cells (Figs. 2A, 2B, respectively).
TABLE. Primary Antibody and Taqman Probe Information
Antibody Information
Antibody Clone
Source
(Catalog No.)
Mouse anti-cytokeratin
3/12 (CK3/12)
2Q1040 Abcam, Cambridge,
Cambridgeshire, UK
(ab68260)
Mouse anti-cytokeratin
19 (CK19)
BA17 R&D Systems,
Abingdon,
Oxfordshire, UK
(MAB3506)
Mouse anti-pan
cytokeratin (PanCK)
C-11 Thermo Scientific (MA1-
19043)
Rabbit anti-E-cadherin
(E-Cad)
Polyclonal Abcam (ab53033)
Mouse anti-vimentin V9 Vector Labs,
Peterborough,
Cambridgeshire, UK
(VPV684)
Mouse anti-CD34 QBEND10 Abcam (Ab8536)
Rabbit anti-CD73 Polyclonal Abcam (Ab71322)
Mouse anti-CD90 F15-42-1 Thermo Scientific
(MA5-16671)
Goat anti-CD105 Polyclonal R&D Systems (AF1097)
Taqman Probe Information
Protein Name Gene Name Assay ID
Cytokeratin 3 KRT 3 Hs00365074_m1
Cytokeratin 12 KRT12 Hs00165015_m1
Cytokeratin 19 KRT19 Hs00761767_s1
Cytokeratin 5 KRT5 Hs00361185_m1
E-cadherin CDH1 Hs00170423_m1
Vimentin VIM Hs00185584_m1
CD34 CD34 Hs00990732_m1
CD73 NT5E Hs01573922_m1
CD90 THY1 Hs00174816_m1
CD105 ENG Hs00923996_m1
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Imaging of CK3/12 and CK19 staining was performed at
different exposure settings for CEC and CSC; thus brightness of
staining cannot be directly compared. Staining for CK3/12 and
CK19 was considerably brighter in CEC than in CSC. Imaging
of PanCK and E-cadherin was performed at the same exposure
setting. Corneal epithelial cells stained positive for all proteins
(Fig. 2A), although CK3/12 was not seen in every cell, as
shown by the low-magnification image (Fig. 2Ai). CK3/12 (Fig.
2Bi) and CK19 (Figs. 2Bi, 2Bii) were positively stained
throughout the entire CSC population. Corneal stromal cells
did not express panCK (Fig. 2Biv) or E-cadherin (Fig. 2Bv) at
levels detectable above that of the background. Expression of
FIGURE 1. Expression of epithelial, keratocyte, and mesenchymal stromal cell markers in corneal epithelium and stroma. Immunofluorescent
staining was performed on sections of cornea, and representative images were taken of (A) peripheral (limbal) epithelium, (B) peripheral (limbal)
stroma, (C) central epithelium, and (D) central stroma. Epithelial markers were (i) CK3/12, (ii) CK19, (iii) pan cytokeratin (PanCK), and (iv) E-
cadherin (E-Cad). Keratocyte markers included (v) vimentin and (vi) CD34. Mesenchymal stromal cell markers were (vii) CD73, (viii) CD90, and
(ix) CD105. Representative images shown (n¼ 3). Scale bars: 100 lm.
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these markers was further investigated by looking at mRNA
level using RT-qPCR (Figs. 2C–G). Levels of all genes were
significantly lower in CSC than CEC; this was also reflected in
the differences in brightness when immunofluorescence was
performed. However, there were detectable levels of mRNA for
KRT3 (CK3, Fig. 2C), KRT12 (CK12, Fig. 2D), and KRT19
(CK19, Fig. 2E), supporting the immunocytochemistry. There
was no detectable mRNA for KRT5 (CK5, Fig. 2F), which was
tested as one of the proteins detected by the panCK antibody,
or CDH1 (E-cadherin, Fig. 2G).
Expression of Markers of Keratocytes and MSC in
CEC and CSC
Cultured CEC and CSC were immunostained for markers
associated with keratocytes and MSC (Fig. 3). Imaging for CEC
and CSC was performed at identical exposure settings.
Expression of vimentin was uniformly detected in both CEC
(Fig. 3Ai) and CSC (Fig. 3Bi), but the rounded cobblestone
morphology of the CEC was different from the fusiform
morphology of the CSC. Neither CEC nor CSC at this passage
(P4) visibly stained for CD34 (Figs. 3Aii, 3Bii). Corneal stromal
cells stained positive for CD73 (Figs. 3Bi, Bii), CD90 (Fig.
3Biv), and CD105 (Fig. 3Bv). There was light staining for
CD73 (Fig. 3Aiii) and CD90 (Fig. 3Aiv) in CEC. CD105 staining
in CEC (Fig. 3Av) was sparse but did appear in individual
cells, possibly due to fibroblast contamination. Reverse
transcription-qPCR showed that VIM (vimentin, Fig. 3C),
CD34 (Fig. 3D), THY1 (CD90, Fig. 3F), and ENG (CD105, Fig.
3G) were all expressed at significantly higher levels in CSC
than CEC. There were no significant differences in levels of
NT5E (CD73, Fig. 3E).
Differences in Expression Profiles Between High-
Passage (P4), Early Extracted (P0), and Quiescent
CSC
To explore the effect of in vitro expansion and activity state on
phenotypic marker expression, CSC cultured to P4 (high
passage) were compared to early extracted CSC (cells at P0
that would have been passaged to P1 if not fixed for
immunocytochemistry or RNA extracted) and to high-passage
FIGURE 2. Expression of epithelial markers by CSC compared to CEC. Immunocytochemistry was performed on (A) CEC cultured from explants
and (B) CSC cultured in M199 to P4 for (i, ii) CK3/12, (iii) CK19, (iv) pan cytokeratin (PanCK), and (v) E-cadherin. Scale bars: 500 lm (i); 50 lm
(ii–v). Insets show same images with F-actin counterstain. Scale bars: 500 lm (i); 50 lm (ii–v). Reverse transcription-qPCR was performed to assess
differences in mRNA levels of (C) KRT3, (D) KRT12, (E) KRT19, (F) KRT5, and (G) CDH1. Expression of each target gene was normalized to
GAPDH and represented relative to mRNA expression by CEC. Data shown as mean 6 SEM of three experiments (n¼ 3), each with two replicates.
Statistical significance of CEC versus CSC (Student’s t-test) represented by **P  0.01, ***P  0.001.
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CSC that had subsequently been placed into a differentiation
medium to induce quiescence (Fig. 4). Imaging of the
immunocytochemistry was taken at exposure settings identical
to those for P4 CSC (Figs. 2, 3). Early extracted and quiescent
CSC comparably stained for CK3/12 (Fig. 4i) and CK19 (Fig.
4ii), but did not express panCK (Fig. 4iii) or E-cadherin (Fig.
4iv), similar to the P4 CSC (Fig. 2). However, RT-qPCR
demonstrated that mRNA levels for KRT3 (Fig. 4C), KRT12
(Fig. 4D), and KRT19 (Fig. 4E) were significantly lower in early
extracted and quiescent cells than high-passage CSC, which
was not reflected in the immunofluorescence. Quiescent cells
also had significantly lower KRT3 mRNA levels than early
extracted CSC. Expression of KRT5 (Fig. 4F) or CDH1 (Fig. 4G)
was not seen in any group.
Vimentin staining in P0 (Fig. 4Av) and quiescent cells (Fig.
4Bv) appeared comparable to that in high-passage CSC (Fig. 3).
CD34 staining was visible in early extracted CSC (Fig. 4Avi),
was lost by P4 (Fig. 3), but was regained and can be seen in
quiescent CSC (Fig. 4Bvi). CD73, CD90, and CD105 staining
appeared decreased in early extracted CSC (Figs. 4Avii–ix)
compared to high-passage (Fig. 3) and quiescent CSC (Figs.
4Avii–ix). Reverse transcription-qPCR showed that VIM (Fig.
4H) and CD34 (Fig. 4I) mRNA expression was significantly
increased in quiescent cells. NT5E, THY1, and ENG were
significantly increased in quiescent cells compared to both P4
and P0 (Figs. 4J–L).
Expression of Typical Markers of Epithelial Cells
and MSC in WJ-MSC
Mesenchymal stromal cells were extracted from Wharton’s
jelly and cultured using identical processes and medium to
CSC up to P4, prior to phenotypic analysis. Imaging of the
immunocytochemistry was taken at identical exposure
settings to those for P4 CSC (Figs. 2, 3). Wharton’s jelly
MSC stained for CK3/12 (Fig. 5Aii) and CK19 (Fig. 5Aiii) to
some degree, similar to CSC (Fig. 2B). However, unlike CSC,
WJ-MSC stained positively for panCK (Fig. 5Aiv), indicating
expression of one or more of CK4, 5, 6, 8, 13, and 18, and
stained for E-cadherin (Fig. 5Av) despite not being of
FIGURE 3. Expression of keratocyte and mesenchymal stromal cell markers by CSC and CEC. Immunocytochemistry was performed on (A) CEC
cultured from explants and (B) CSC cultured in M199 to P4 for (i) vimentin, (ii) CD34, (iii) CD73, (iv) CD90, and (v) CD105. Scale bars: 100 lm.
Reverse transcription-qPCR was performed to assess differences in mRNA levels of (C) VIM, (D) CD34, (E) NT5E, (F) THY1, and (G) ENG.
Expression of each target gene was normalized to GAPDH and represented relative to mRNA expression by CEC. Data shown as mean 6 SEM of
three experiments (n¼ 3), each with two replicates. Statistical significance of CEC versus CSC (Student’s t-test) represented by *P  0.05, **P 
0.01, ***P  0.001, ****P  0.0001.
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FIGURE 4. Expression of epithelial, keratocyte, and mesenchymal stromal markers in early extracted and quiescent CSC. Immunocytochemistry was
performed on (A) P0 CSC and (B) quiescent CSC staining for (i) CK3/12, (ii) CK19, (iii) pan cytokeratin (PanCK), (iv) E-cadherin, (v) vimentin, (vi) CD34,
(vii) CD73, (viii) CD90, and (ix) CD105. Scale bars: 50 lm (i–iv); 100 lm (v–ix). Reverse transcription-qPCR was performed to assess differences in
mRNA levels between P4, P0, and quiescent CSC of (C) KRT3, (D) KRT12, (E) KRT19, (F) KRT5, (G) CDH1, (H) VIM, (I) CD34, (J) NT5E, (K) THY1, and
(L) ENG. Expression of each target gene was normalized to GAPDH and represented relative to mRNA expression of P4 CSC. Data shown as mean 6 SEM
of three experiments (n¼ 3), each with two replicates. Statistical significances analyzed by 1-way ANOVA represented by *P  0.05, **P  0.01, ***P 
0.001, ****P  0.0001.
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epithelial origin. Wharton’s jelly MSC showed expression of
vimentin (Fig. 5Avi), CD73 (Fig. 5Aviii), CD90 (Fig. 5Aix), and
CD105 (Fig. 5Ax), but similarly to P4 CSC (Fig. 3) did not
express CD34 (Fig. 5Avii). Reverse transcription-qPCR re-
vealed significantly decreased expression of KRT3 (Fig. 5B),
KRT12 (Fig. 5C), and KRT19 (Fig. 5D) compared to CSC.
Inversely, WJ-MSC had detectable levels of both KRT5 and
CDH1, which did not occur in CSC. Wharton’s jelly MSC
showed mRNA expression of VIM (Fig. 5G), NT5E (Fig. 5I),
and THY1 (Fig. 5J) similar to the CSC, but downregulation of
CD34 (Fig. 5H) and ENG (Fig. 5K).
Cytokeratin Expression in Stromal Cells
A semiquantitative cell-based immunoassay was used to
compare CK3/12, CK19, and panCK staining in ihCEC, P4
FIGURE 5. Expression of epithelial and mesenchymal stromal cell markers in WJ-MSC. (A) Immunocytochemistry was performed on WJ-MSC
staining for (i) F-actin (ii) CK3/12, (iii) CK19, (iv) pan cytokeratin (PanCK), (v) E-cadherin, (vi) vimentin, (vii) CD34, (viii) CD73, (ix) CD90, and
(x) CD105. Scale bars: 50 lm (i–v); 100 lm (vi–x). Reverse transcription-qPCR was performed to assess differences in mRNA levels between CSC
and WJ-MSC investigating (C) KRT3, (D) KRT12, (E) KRT19, (F) KRT5, (G) CDH1, (H) VIM, (I) CD34, (J) NT5E, (K) THY1, and (L) ENG. Expression
of each target gene was normalized to GAPDH and represented relative to mRNA expression by WJ-MSC. Data shown as mean 6 SEM of three
experiments (n ¼ 3), each with two replicates. Statistical significances analyzed by 1-way ANOVA represented by *P  0.05, **P  0.01, ***P 
0.001.
FIGURE 6. Quantitation of cytokeratin staining in stromal cells. A quantitative cell-based fluorescent immunoassay was performed and fluorescence
intensity determined for (A) CK3/12, (B) CK19, and (C) PanCK, staining in ihCEC, P4 CSC, P1 CSC, quiescent CSC, and WJ-MSC. Fluorescent
intensity of antigen for all groups was corrected for cell number using fluorescent intensity of actin staining and is displayed relative to intensity in
ihCEC. Data shown as mean 6 SD of three experiments (n¼ 3), each with 100 readings. Statistical significances versus ihCEC analyzed by 1-way
ANOVA represented by *P  0.05, **P  0.01, ***P  0.001, ****P  0.0001. Statistical significances versus WJ-MSC analyzed by one-way ANOVA
represented by ####P  0.0001.
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CSC, P0 CSC, quiescent CSC, and WJ-MSC (Fig. 6). Data
reflected the previous immunocytochemistry. CK3/12 was
significantly lower in CSC P4, CSC P0, quiescent CSC, and WJ-
MSC than ihCEC, but levels were still over 50% (Fig. 6A). CK19
was reduced in all stromal cells compared to ihCEC, at levels
between 10% and 20%; however, staining was detectable above
background (Fig. 6B). PanCK was detectable above back-
ground levels only in ihCEC and WJ-MSC (Fig. 6C). Levels in
WJ-MSC were significantly higher than in CSC but significantly
lower than in ihCEC.
DISCUSSION
Identification of mammalian cells, both in vivo and in vitro, can
usually be reliably performed by detecting specific cell surface
markers, or IF of the cytoskeleton.39,40 Corneal epithelial and
stromal cells have clear differences in protein and IF
expression profiles in vivo, which are often used to differen-
tiate between the cell types in vitro. Notably, the epithelium
expresses cytokeratins that are not expressed by keratocytes.
Corneal epithelial cells are also known to express different
cytokeratins depending on differentiation state. In this study,
CK3/12 was seen only in the terminally differentiated cells of
the central epithelium and was not present in the peripheral/
limbal epithelium, as has been described many times previ-
ously.10,41,42 CK19 was present only in a limited number of
cells, focused only in the limbal region of the epithelium, as
described previously.10,43
There is little evidence to suggest that CK3, CK12, or CK19
is expressed in vivo by keratocytes. However, this study clearly
demonstrates that in vitro culture not only causes phenotypical
changes in CSC but also induces expression of specific
cytokeratins. Expression of CK3, CK12, and CK19 was induced
as CSC were cultured in vitro, as shown by immunocytochem-
istry. Although mRNA levels of these cytokeratins were much
lower in CSC than CEC, the immunocytochemistry demon-
strated that the filaments were clearly visible and therefore that
a functional cytokeratin protein was being transcribed. Culture
of CSC promotes an atypical, active state that may explain the
change in IF expression, alongside the induction of other
markers such as CD73, CD90, and CD105. Culture appeared to
induce specific, corneal-related cytokeratins, as no staining was
seen when a panCK antibody, specific for CK4, 5, 6, 8, 13, and
18, was used. This was further corroborated by the fact that
CSC did not express the KRT5 gene, whereas CEC did. Corneal
epithelial cells stained positive for panCK, both in vivo and in
vitro, suggesting that they also express one or more of CK4, 5,
6, 8, 13, and 18. However, direct comparisons between
cultured CEC and CSC in this study are difficult to perform due
to the different culture requirements of the cells, particularly
the different culture media used.
The observed lower mRNA levels in CSC compared to CEC
may explain why other groups have not detected cytokeratins
in cultured CSC during nonquantitative RT-PCR experi-
ments.30,44 There have also been studies performed that have
shown no expression of cytokeratins during flow cytometry
experiments.31,35,36 However, it was not mentioned whether
the flow cytometry procedure included cell permeabilization,
required for detecting cytoplasmic antigens.45,46 In our
staining procedures, we include permeabilization for intracel-
lular antigens, and we were able to detect cytokeratins visually
by immunocytochemistry and to semiquantify the amount of
cytokeratin by plate reader assay.
Earlier-passage CSC expressed lower mRNA levels of CK3,
CK12, and CK19 than later passages, supporting the hypoth-
esis that prolonged culture and proliferation drive cytokeratin
expression. Other phenotypic changes occurred upon passage,
including decreased expression of CD34, as described previ-
ously,25 and increased levels of CD105 and CD90, a protein not
present in the healthy cornea.27 Attempts to differentiate the
cells back to a keratocyte phenotype using serum-free medium,
as performed previously,47,48 led to further phenotypic
changes. Quiescent cells expressed decreased levels of
cytokeratin genes KRT3, KRT12, and KRT19 compared to
the proliferative cells, but protein and gene did not disappear,
suggesting that differentiation had not resulted in a keratocyte
phenotype. The major effect of quiescence was a large
upregulation of the gene for CD34, indicating some differen-
tiation. However, the quiescent CSC also showed increased
expression of CD90 and CD105. For this reason, we do not
believe that the quiescent CSC in this study are comparable to
the native keratocyte, at this point. Although serum-free
medium may induce expression of keratocyte markers such
as CD34, this also needs to be reflected in the downregulation
of markers such as CD90 and CD105. Differentiation may have
been incomplete, and downregulation of the fibroblast markers
might have occurred if the cells had been differentiated for a
longer time period.
A number of studies have been performed that demonstrate
the ability of CSC isolated from the limbal stroma to conform to
a set of minimal criteria set by the ISCT, which define an
MSC.30–32,49 These criteria state that to be considered a
population of MSC, the cells should be plastic adherent; over
95% of cells should express CD73, CD90, and CD105; under
2% of cells should express CD11b, CD14, CD19, CD34, CD45,
and HLA-DR; and the cells should possess the ability to undergo
adipogenesis, osteogenesis, and chondrogenesis in vitro.50
However, this study shows that although these limbal CSC
become MSC after extraction and several passages,31 there is
no evidence that the in vivo limbal stroma contains MSC as
defined by the ISCT. This is due primarily to a lack of
expression of CD90 and high expression of CD34 by in vivo
keratocytes. CD90 is rarely present in a healthy cornea as it is a
marker of activated keratocytes.27 CD34 is a cell surface marker
associated with progenitor cells and quiescence51; its associ-
ation with hematopoietic stem cells is the reason it is
considered an indicator that a cell is not an MSC.
For further investigation into cytokeratin expression in
mesenchyme-derived cells, we compared expression in CSC to
another MSC-like cell type: MSC extracted from the Wharton’s
jelly of the umbilical cord. Wharton’s jelly MSC have been
previously characterized as having an MSC phenotype,52–54
similar to that displayed by CSC. Wharton’s jelly MSC showed
detectable expression of CK3, CK12, and CK19, although
relative mRNA levels were lower than those in CSC. In contrast
to CSC, WJ-MSC showed positive staining for the panCK
antibody and had detectable levels of mRNA for KRT5 (CK5),
suggesting that there is some specificity in the cytokeratins
produced by different stromal cells. There were also detectable
levels of E-cadherin, which could indicate epithelial contam-
ination; however, immunocytochemistry demonstrated that
the cells appeared to have a fibroblastic morphology and not
the cobblestone morphology seen in cultured epithelial cells.
This is not the first report of cytokeratin expression in
extracted and cultured keratocytes.34 However, this is the first
to report CK19 expression and the fact that there is some
specificity to the cytokeratins expressed in different stromal
cell populations. Cytokeratin expression has also been
described in a number of stromal cell types from different
tissues. One of the first reports of this was in 1987, when von
Koskull39 demonstrated staining for CK8, CK18, and CK19 in
decidual stromal cells and fetal fibroblasts. Conget and
Minguell55 detected a number of cells expressing panCK
(clone K3.18), CK18, and CK19, but did not detect any other
epithelial markers by flow cytometry in bone marrow–
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derived MSC. Similar to this study, cytokeratins have also been
detected in umbilical cord stromal cells.56 In this case it was a
panCK antibody with a mixture of clones that detected CK1,
4, 5, 6, 8, 10, 13, 18, and 19 by immunocytochemistry,
alongside vimentin and myofibroblast marker a-smooth
muscle actin. It has also been shown that adipose-derived
stromal cells acquire CK3, CK76, and CK12 over time in
culture, but not CK1, 5, 10, or 14,57 further suggesting that
there is specificity to the expression of cytokeratins by
stromal cells.
Results in this study show that the expression profile of
cultured CSC can become much more similar to that of CEC
than previously thought. This may indicate that CSC possess
the ability to transition into an epithelial phenotype, and
adds to increasing evidence that CSC extracted from the
limbal region have stem cell properties. Previous work by our
group has demonstrated the ability of CD34þ CSC to
transdifferentiate into a CEC phenotype in vitro,25 and if
this is possible, there is scope for CSC to be used within a
regenerative cell therapy for the treatment of ocular surface
disorders.
In conclusion, cultured CSC and other types of stromal
cells can acquire a very different phenotype from that of an in
vivo keratocyte, which can include the expression of
cytokeratins. Investigators should be careful not to compart-
mentalize cytokeratin expression as an epithelial-only char-
acteristic and should be careful not to assume that the in vitro
phenotype of extracted primary cells reflects the state of the
healthy tissue. When culturing CSC, investigators need to be
aware that expression of these markers is not necessarily due
to epithelial contamination; and to check for contamination,
an alternative epithelial marker, such as E-cadherin, should be
used.
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